19
HERRERA ET AL .
TABLE 7
Timeline of the guideline development process.
Timepoint
Action
April 2018
Decision by European Federation of Periodontology (EFP) General Assembly to develop comprehensive treatment guidelines for periodontitis and peri-implant diseases EFP Workshop Organizing Committee (WOC) assesses merits and disadvantages of various established methodologies and their applicability to the field EFP WOC decides on (i) topics covered by proposed guideline, (ii) working groups and chairs, (iii) systematic reviewers and (iv) outcome measures
May – September 2018
November 2021
February 2022
EFP WOC decides invited systematic reviewers
March2022
Decision on consensus group, invitations sent to participants, invitations sent to stakeholders
March2022
Submission of PICO(S) questions by systematic reviewers to group chairs for internal alignment
March 30th, 2022
Online meeting with consultant, WOC and reviewers, to better define PICOS. Final decision by WOC on PICOS
April 2022
Decision on PICO(S) and information sent to reviewers
June – August 2022
Submission of systematic reviews to WOC by the reviewers, initial quality assessment
August – September 2022
Submission to Journal of Clinical Periodontology , peer review and revision process
September – December 2022
Peer review and revision process in Journal of Clinical Periodontology
26 September 2022
Online plenary meeting
28 September 2022
Online working group meetings
September – October 2022
Submission of declarations of interest by all delegates
19 October 2022
Online working group meetings
October 2022
Electronic circulation of reviews
6 – 9 November, 2022
Workshop in La Granja with moderated formalized consensus process
November 2022 – January 2023
Formal stakeholder consultation, finalize guideline method, report and background text
18 January, 2023
Online plenary meeting
February 2023
Submission of guideline document to the Journal of Clinical Periodontology
April 2023
Publication of guideline and underlying systematic reviews in the Journal of Clinical Periodontology
April – September 2023
Processes of adaptation/adoption by National Societies
• Treatment of peri-implantitis (surgical) • Secondary prevention of peri-implant mucositis • Secondary prevention of peri-implantitis
• patients awaiting dental implant rehabilitation; • patients receiving dental implant rehabilitation; • patients already rehabilitated using dental implant(s).
Subsequently, interventions were organized according to the clin- ical status of the peri-implant tissues:
4.2
| Management according to the stage of
implant therapy
• before dental implant placement; • healthy peri-implant tissues; • peri-implant mucositis; • peri-implantitis; • following treatment of peri-implant mucositis; • following treatment of peri-implantitis.
Three different clinical scenarios exist (Figure 1):
• patients awaiting dental implant rehabilitation (pre-operative) • patients receiving dental implant rehabilitation (peri-operative) • patients already having dental implant/s (post-operative)
This guideline has been organized into interventions following these different stages of peri-implant tissue management:
4.2.1 | Pre-operative interventions
• Risk factor control before implant placement • Risk factor control during implant/prosthesis placement • Maintenance of peri-implant tissue health • Treatment of peri-implant mucositis • Treatment of peri-implantitis (non-surgical)
Due to the high prevalence of peri-implant diseases (described in Section 1), any patient receiving dental implants should be considered at risk of developing some form of peri-implant disease. Once the dental implant/abutment complex is exposed to the oral environment,
Made with FlippingBook Annual report